Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26094
Title: Comparing the EQ-5D-3L anxiety or depression domain to the Hospital Anxiety and Depression Scale to identify anxiety or depression after stroke.
Austin Authors: Thayabaranathan, Tharshanah;Andrew, Nadine E;Stolwyk, Rene;Lannin, Natasha A;Cadilhac, Dominique A
Affiliation: Alfred Health, Melbourne, Victoria, Australia
Turner Institutefor Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia
Monash-Epworth Rehabilitation Research Centre, Richmond, Australia
Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Victoria, Australia
Central Clinical School, Monash University, Frankston, Victoria, Australia
The Florey Institute of Neuroscience and Mental Health
Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia
Issue Date: 2022
Date: 2021-03-17
Publication information: Topics in stroke rehabilitation 2022; 29(2): 146-155
Abstract: Background: Anxiety and depression are common post-stroke and impact quality-of-life (QoL). The EQ-5D three-level version (EQ-5D-3L) is increasingly used to routinely measure health-related QoL in stroke populations, but its potential value for detecting anxiety or depression is uncertain. We sought to examine the agreement and convergent validity of the EQ-5D-3L anxiety or depression domain in survivors of stroke.Methods: Cross-sectional survey data obtained from participants in the Australian Stroke Clinical Registry (AuSCR) between 90 and 180 days after stroke were used. Correlation, sensitivity, specificity, and the area under the curve were calculated for the EQ-5D-3L anxiety or depression domain against the Hospital Anxiety Depression Scale (HADS, reference standard), which has been validated as a screening measure following stroke.Results: Data were obtained from 245 respondents (median time post-stroke 143 days), median age 74 years; 42% female. Nearly 50% reported problems (43% moderate; 7% extreme) in the EQ-5D-3L anxiety or depression domain. The median HADS-Anxiety score was 6 (Q1:3, Q3:9), and the median HADS-Depression score was 5 (Q1:2, Q3:9). The EQ-5D-3L anxiety or depression scores were strongly correlated (r = 0.58) with scores of the HADS-Anxiety, but moderately correlated with HADS-Depression (r = 0.37), and combined HADS-Anxiety or HADS-Depression (r = 0.46). The EQ-5D-3L anxiety or depression domain had greater sensitivity and specificity in identifying cases with anxiety than in identifying depressive symptoms in survivors of stroke.Conclusions: The EQ-5D-3L appears to have value as a population level indicator of anxiety or depression following stroke. Further validation against "gold standard" clinical assessment is required for clinical applications.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26094
DOI: 10.1080/10749357.2021.1895494
ORCID: 0000-0003-2504-7772
0000-0002-4846-2840
0000-0002-4975-3332
0000-0002-2066-8345
0000-0001-8162-682X
Journal: Topics in Stroke Rehabilitation
PubMed URL: 33726636
Type: Journal Article
Subjects: Anxiety
depression
mass screening
registries
sensitivity
specificity
Appears in Collections:Journal articles

Show full item record

Page view(s)

20
checked on Apr 17, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.